Skip to content
cx516

Structure via PubChem · Public domain (PubChem)

EntityQ5014875· pop 5· linked from 833 articles

Also known as BDP-12, CX 516, CX-516

CX-516 is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator and had been undergoing development by a collaboration between Cortex, Shire, and Servier. It was studied as a potential treatment for Alzheimer's disease under the brand name Ampalex, and was also being examined as a treatment for ADHD.

In the Vinony graph

Vinony's link graph records 833 inbound references to cx516, and connects out to AMPA receptor, pentamidine and 1-aminocyclopropanecarboxylic acid.

It sits within the topics 1-Piperidinyl compounds, Abandoned drugs and Ampakines.

Vinony links it to 5 Wikipedia language editions.

Chemical data

Formula
C14H15N3O
Molecular weight
241.29 g/mol
IUPAC name
piperidin-1-yl(quinoxalin-6-yl)methanone
SMILES
C1CCN(CC1)C(=O)C2=CC3=NC=CN=C3C=C2
InChIKey
ANDGGVOPIJEHOF-UHFFFAOYSA-N
XLogP
1.8
Polar surface area
46.1 Ų
H-bond donors
0
H-bond acceptors
3
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Phase 2
Molecule type
Small molecule
Indications
Cognitive impairment, schizophrenia

via ChEMBL · EBI

Wikidata facts

Mass
241.122
Show 2 more facts
chemical formula
C₁₄H₁₅N₃O
canonical SMILES
C1CCN(CC1)C(=O)C2=CC3=NC=CN=C3C=C2
Sources (2)

via Wikidata · CC0

~1 min read

Encyclopedic overview

2 sections
Contents
  • See also
  • References

CX-516 is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator and had been undergoing development by a collaboration between Cortex, Shire, and Servier. It was studied as a potential treatment for Alzheimer's disease under the brand name Ampalex, and was also being examined as a treatment for ADHD.

CX-516 was the first ampakine compound developed by Cortex and while it showed good in vitro activity and positive results in animal tests, the human trials proved disappointing due mainly to low potency and short half-life. However, CX-516 is still widely used in animal research into the ampakine drugs and is the standard reference compound that newer, more potent drugs of this class such as farampator and CX-717 are compared to.

Excerpted from Wikipedia’s “cx516” article, available under the CC BY-SA 4.0 licence.

Available in 5 languages

via Wikidata sitelinks · CC0

Connections

Categories